Associate Principal Ai Solutions Architect - Evinova

Astrazeneca - Barcelona onsite - 3 days at office/2 days at home

It currently takes over 10 years and $1.3B to develop a drug. More than 70% of that investment goes into clinical trials, yet only ~10% of candidates make it from Phase I to approval. Evinova—a new health-tech business within the AstraZeneca Group—is here to change the math. We use advanced algorithms and GenAI to aim high: boosting clinical trial success by 20%, cutting development time by 3 years, and halving study costs. We are looking for a skilled Associate Principal AI Solutions Architect or Principal AI Solutions Architect who operates at the intersection of Data Science and Business Strategy.